What does complement do in Alzheimer's disease? Old molecules with new insights.
about
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levelsThe Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's DiseaseAPOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspectiveMedicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticalsTemporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.Tau passive immunization inhibits not only tau but also Aβ pathologyConnecting genetic risk to disease end points through the human blood plasma proteomeAge-related increases in amyloid beta and membrane attack complex: evidence of inflammasome activation in the rodent eye.Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.Targeting microglia for the treatment of Alzheimer's Disease.Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.Diverse Protein Profiles in CNS Myeloid Cells and CNS Tissue From Lipopolysaccharide- and Vehicle-Injected APP/PS1 Transgenic Mice Implicate Cathepsin Z in Alzheimer's Disease
P2860
Q26751302-E33AF81A-4B0F-4D7F-B0B9-2D4062A7F7FBQ26781815-D76E660C-03CC-4F77-B4F0-73DB51F4B17CQ28085213-5BC5C5AB-B63F-49A3-AB51-0EDD83BD0C7FQ29026697-1402D13A-A165-48DD-8FE1-4B12F2CCB36CQ34545200-B0B80A26-D4AF-4FD5-AEE4-A2D244D26AE9Q37579019-CA167046-A32D-43A0-82D0-2B4AB195F102Q37676698-20E61988-F415-4ADF-9FEA-3984FF98F987Q41575018-560FB64C-0971-4F5B-A7C7-13829DD17144Q47700598-D8F7CECB-A475-4BEA-9AB8-927B814700CEQ50331861-7208F3AD-7751-4769-B6ED-3CD0C13CEDC3Q53376999-40D358E5-E00C-4ADA-9922-9C9FB4BDE940Q55304161-C40E2352-27E6-4B04-9783-9E5A3DE24160Q55365163-043E29D3-7D71-44D8-8E80-B6E1660C9C4CQ55686847-4FA3D1B4-21DD-4536-BE16-9A516A11B94BQ59128213-6F440E7E-3614-45CD-900D-D7720EA5E549
P2860
What does complement do in Alzheimer's disease? Old molecules with new insights.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
What does complement do in Alzheimer's disease? Old molecules with new insights.
@en
What does complement do in Alzheimer's disease? Old molecules with new insights.
@nl
type
label
What does complement do in Alzheimer's disease? Old molecules with new insights.
@en
What does complement do in Alzheimer's disease? Old molecules with new insights.
@nl
prefLabel
What does complement do in Alzheimer's disease? Old molecules with new insights.
@en
What does complement do in Alzheimer's disease? Old molecules with new insights.
@nl
P2093
P2860
P356
P1476
What does complement do in Alzheimer's disease? Old molecules with new insights.
@en
P2093
P2860
P2888
P356
10.1186/2047-9158-2-21
P577
2013-10-12T00:00:00Z
P5875
P6179
1035326760